Synthetic heparin derivatives as new anticoagulant drugs
- 1 June 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (11) , 769-779
- https://doi.org/10.1016/s1359-6446(05)03457-4
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosisJournal of Thrombosis and Haemostasis, 2004
- Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudinExpert Opinion on Investigational Drugs, 2004
- The Influence of Hinge Region Residue Glu-381 on Antithrombin Allostery and MetastabilityPublished by Elsevier ,2004
- Chemical Contributions to Understanding Heparin Activity: Synthesis of Related Sulfated OligosaccharidesEuropean Journal of Organic Chemistry, 2003
- Molecular Determinants of the Mechanism Underlying Acceleration of the Interaction between Antithrombin and Factor Xa by Heparin PentasaccharidePublished by Elsevier ,2002
- Experimental Proof for the Structure of a Thrombin-Inhibiting Heparin MoleculeChemistry – A European Journal, 2001
- Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trialPublished by Oxford University Press (OUP) ,2000
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Glycosaminoglycans: Synthetic fragments and their interaction with serine protease inhibitorsPublished by Walter de Gruyter GmbH ,1995
- The Structure of a Complex of Recombinant Hirudin and Human α-ThrombinScience, 1990